GenprexGNPX
13F holders, Q4 2025 (December 31)22holders +21
21new positions
0sold out
$1.82avg. 13F price*
At the end of Q4 2025, 22 institutions reported holding Genprex Inc. (GNPX) in their 13F filings, up 21 from Q3 2025. 21 opened new positions and 0 sold out. The largest holders were Tower Research Capital LLC (TRC) ($6K), Cheviot Value Management, LLC ($2K) and Miller Wealth Advisors, LLC ($2K).
- Company
- Genprex Inc.
- CUSIP
- 372446302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 21 | $13K |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 7,107 shares bought and 2,373 shares sold, net +4,734 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,280 | $6K |
| Cheviot Value Management, LLC | 0.00% | New | 1,000 | $2K |
| Miller Wealth Advisors, LLC | 0.00% | New | 1,200 | $2K |
| Jones Financial Companies LLLP | 0.00% | New | 1,055 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 232 | $404 |
| BlackRock, Inc. | 0.00% | New | 188 | $329 |
| UBS Group AG | 0.00% | New | 94 | $165 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -98.0% | 48 | $84 |
| Bank of America Corp. | 0.00% | New | 18 | $31 |
| HighMark Wealth Management LLC | 0.00% | New | 10 | $17 |
| Morgan Stanley | 0.00% | New | 6 | $11 |
| Nemes Rush Group LLC | 0.00% | New | 5 | $9 |
| Citigroup Inc. | 0.00% | New | 4 | $7 |
| Allworth Financial LP | 0.00% | New | 3 | $6 |
| FMR LLC | 0.00% | New | 3 | $5 |
| JPMorgan Chase & Co. | 0.00% | New | 2 | $4 |
| Group One Trading LLC | 0.00% | New | 2 | $4 |
| Danske Bank A/S | 0.00% | New | 1 | $2 |
| Global Retirement Partners, LLC | 0.00% | New | 1 | $2 |
| Curio Wealth, LLC | 0.00% | New | 1 | $2 |
| Capital Advisors, Ltd. LLC | 0.00% | New | 1 | $0 |
| Motiv8 Investments LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is GNPX's weight in each manager's 13F, not the share of Genprex Inc. the manager owns.